P53 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma
Yohei Sekino(Hiroshima University), Jun Teishima(Hiroshima University)
Cited by 10
Related Papers
KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer
|Journal of Clinical Medicine|2019|55
PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell Carcinoma
|Anticancer Research|2020|31
CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma
|Anticancer Research|2021|13
HOXB5 Overexpression Is Associated with Neuroendocrine Differentiation and Poor Prognosis in Prostate Cancer
|Biomedicines|2021|9
KIFC1 inhibitor CW069 induces apoptosis and reverses resistance to docetaxel in prostate cancer
|European Urology Supplements|2019|0